http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749056-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae2be58a477cef66248d0dc28cb0ea82
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
filingDate 2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2adfa990a530acfdae56f8bc389b5242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03f7ce6f26ad604e319daefb1d68be57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5d2b1b837c399ad479587473381910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ab7ad66ae9a3cadaaac10fb2a70f011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d405c60a13a51ecc9edf794edb0147c1
publicationDate 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106749056-A
titleOfInvention A kind of Bola type ribavirin compound and its preparation method and application
abstract The present invention relates to a kind of Bola type ribavirin compound, the structure is as shown in general formula I, by researching the characteristic of this special structure of Bola type amphiphile molecule, to 1,2,4-ribavirin ribavirin The structure of Wellin is optimized to improve its water solubility and inhibition rate of cancer cell growth. Furthermore, this type of compound has the ability to self-assemble in aqueous solution to form nanoscale particles, which also makes it easier to gather in tumor tissues to achieve targeted drug delivery due to the high permeability and retention effect of solid tumors. It can encapsulate other small molecule drugs to achieve the effect of combined drug. In the general formula, n, R 1 , R 2 , R 3 and R 4 are as defined in the claims.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110590686-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113999279-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110590686-A
priorityDate 2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016280676-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467515120

Total number of triples: 31.